Narcolepsy following COVID‐19: A case report and review of potential mechanisms


Yazdani Roya, 1 Barzkar Farzaneh, 2 Almasi‐Dooghaee Mostafa, 1 Shojaie Mahsa, 1 and Zamani Babak 1 Clin Case Rep. 2023 Jun; 11(6): e7370. Published online 2023 May 25.https://doi.org/10.1002/ccr3.7370, PMCID: PMC10213711, PMID: 37251741 Abstract Key Clinical Message The immune activation in COVID‐19 may…[...]

Narcolepsy following COVID‐19: A case report and review of potential mechanisms


Yazdani Roya, 1 Barzkar Farzaneh, 2 Almasi‐Dooghaee Mostafa, 1 Shojaie Mahsa, 1 and Zamani Babak 1 Clin Case Rep. 2023 Jun; 11(6): e7370. Published online 2023 May 25. doi: 10.1002/ccr3.7370 PMCID: PMC10213711, PMID: 37251741 Key Clinical Message The immune activation in COVID‐19 may trigger narcolepsy…[...]

Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD


Wen-Jan Tuan,a,⁎ Dara E. Babinski,b David P. Rabago,a,b,c and Aleksandra E. Zgierskac Abstract Adults with attention deficit hyperactivity disorder (ADHD) have shown higher infection rates and worse outcomes from COVID-19. Stimulant medications are prescribed…[...]